National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Chronic Myeloproliferative Disorders Treatment (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 08/01/2008



General Information About Chronic Myeloproliferative Disorders






Chronic Myelogenous Leukemia






Polycythemia Vera






Chronic Idiopathic Myelofibrosis






Essential Thrombocythemia






Chronic Neutrophilic Leukemia






Chronic Eosinophilic Leukemia






Stages of Chronic Myeloproliferative Disorders






Treatment Option Overview






Treatment Options for Chronic Myeloproliferative Disorders






To Learn More About Chronic Myeloproliferative Disorders






Get More Information From NCI






Changes to This Summary (08/01/2008)






About PDQ



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Chronic Idiopathic Myelofibrosis

Key Points for This Section


Chronic idiopathic myelofibrosis is a disease in which abnormal blood cells and fibers build up inside the bone marrow.

The bone marrow is made of tissues that make blood cells (red blood cells, white blood cells, and platelets) and a web of fibers that support the blood-forming tissues. In chronic idiopathic myelofibrosis, large numbers of blood stem cells develop into blood cells that do not mature properly (blasts). The web of fibers inside the bone marrow also becomes very thick (like scar tissue) and slows the blood-forming tissue’s ability to make blood cells. This causes the blood-forming tissues to make fewer and fewer blood cells. In order to make up for the low number of blood cells made in the bone marrow, the liver and spleen begin to make the blood cells.

Possible signs of chronic idiopathic myelofibrosis include pain below the ribs on the left side and feeling very tired.

Chronic idiopathic myelofibrosis often does not cause early symptoms. It is sometimes found during a routine blood test. The following symptoms may be caused by chronic idiopathic myelofibrosis or by other conditions. A doctor should be consulted if any of these problems occur:

  • Feeling pain or fullness below the ribs on the left side.
  • Feeling full sooner than normal when eating.
  • Feeling very tired.
  • Shortness of breath.
  • Easy bruising or bleeding.
  • Petechiae (flat, red, pinpoint spots under the skin that are caused by bleeding).
  • Fever.
  • Night sweats.
  • Weight loss.

A special blood test is used to diagnose chronic idiopathic myelofibrosis.

In addition to a complete blood count, bone marrow aspiration and biopsy, and cytogenetic analysis, a peripheral blood smear is used to diagnose chronic idiopathic myelofibrosis. A peripheral blood smear is a procedure in which a sample of blood is checked for tear drop-shaped red blood cells, the number and kinds of white blood cells, the number of platelets, and the presence of blast cells.

Certain factors affect prognosis (chance of recovery) and treatment options for chronic idiopathic myelofibrosis.

Prognosis (chance of recovery) depends on the following:

  • The age of the patient.
  • The number of abnormal red blood cells and white blood cells.
  • The number of blasts in the blood.
  • Whether there are certain changes in the chromosomes.
  • Whether the patient has symptoms such as fever, night sweats, or weight loss.

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov